siRNA treatment decreases triglycerides in people with rare health condition

.ANALYSIS EMPHASIZE.19 September 2024.

Plozasiran decreased triglyceride amounts through 80% as well as lowered the danger of pancreatitis in people with persistent chylomicronemia, with or without a hereditary diagnosis.